Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Supercritical Fluid Chromatography

Supercritical Fluid Chromatography

Supercritical fluid chromatography (SFC) provides a beneficial substitute for gas chromatography (GC) and liquid chromatography (LC) for certain samples because it merges the top attributes of both techniques. SFC allows the separation and analysis of compounds that GC or LC does not easily manage. These compounds are traditionally nonvolatile or thermally unstable, making GC unsuitable and lacking functional groups required for HPLC analysis.
SFC utilizes a supercritical fluid mobile phase,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Biomarkers for Immune Checkpoint Inhibitor-Induced Myocarditis: Caution Needed.

JACC. CardioOncology·2023

Same author

Type 2 Myocardial Infarction: Do We Need Risk Scores?

Journal of the American College of Cardiology·2023

Same author

Accuracy and Clinical Impact of Estimating Low-Density Lipoprotein-Cholesterol at High and Low Levels by Different Equations.

Biomedicines·2022

Same author

Artificial intelligence-augmented electrocardiography for left ventricular systolic dysfunction in patients undergoing high-sensitivity cardiac troponin T.

European heart journal. Acute cardiovascular care·2022

Same author

Measuring copeptin, a surrogate for vasopressin in patients with hypertension - Can it identify those who are volume Responsive?

Clinical biochemistry·2022

Same author

Implementation of High-Sensitivity Cardiac Troponin Assays in the United States.

Journal of the American College of Cardiology·2022

Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026

Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026

Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026

Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026

Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026

Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 17, 2026

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins

Published on: October 4, 2017

Soluble ST2--analytical considerations.

Thomas Mueller¹, Allan S Jaffe²

¹Department of Laboratory Medicine, Konventhospital Barmherzige Brueder, Linz, Austria.

The American Journal of Cardiology

|February 21, 2015

Summary

This summary is machine-generated.

Soluble ST2 (sST2) is a biomarker indicating increased inflammation and heart disease. Measuring sST2 levels provides valuable prognostic information for cardiac patients and even in general populations.

More Related Videos

Purification of Human S100A12 and Its Ion-induced Oligomers for Immune Cell Stimulation

Purification of Human S100A12 and Its Ion-induced Oligomers for Immune Cell Stimulation

Published on: September 29, 2019

Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092

Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092

Published on: October 2, 2017

Related Experiment Videos

Last Updated: Apr 17, 2026

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins

Targeting Cysteine Thiols for in Vitro Site-specific Glycosylation of Recombinant Proteins

Published on: October 4, 2017

Purification of Human S100A12 and Its Ion-induced Oligomers for Immune Cell Stimulation

Purification of Human S100A12 and Its Ion-induced Oligomers for Immune Cell Stimulation

Published on: September 29, 2019

Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092

Biochemical and Structural Characterization of the Carbohydrate Transport Substrate-binding-protein SP0092

Published on: October 2, 2017

Area of Science:

Biochemistry
Immunology
Cardiology

Background:

Suppression of tumorigenicity 2 (ST2) exists as transmembrane (ST2L) and soluble (sST2) isoforms.
ST2L acts as a receptor for IL-33, while sST2 functions as a decoy receptor, inhibiting IL-33/ST2L signaling.
Elevated sST2 blood concentrations are observed in inflammatory and heart diseases, serving as a prognostic marker.

Purpose of the Study:

To review the analytical considerations for measuring circulating sST2.
To highlight the clinical utility of sST2 as a prognostic biomarker in cardiac diseases.
To discuss pre-analytical and post-analytical factors influencing sST2 measurement.

Main Methods:

Literature review of studies on ST2 isoforms and their clinical applications.
Analysis of factors affecting sST2 measurement, including stability and biological variation.
Examination of reference ranges and comparisons with diseased cohorts.

Main Results:

sST2 is a clinically useful prognostic biomarker in cardiac diseases, even in low-risk populations.
sST2 levels are elevated in inflammatory conditions and heart disease.
Analytical considerations are crucial for accurate sST2 measurement.

Conclusions:

Circulating sST2 is a valuable prognostic biomarker in cardiovascular diseases.
Understanding analytical and pre-analytical factors is essential for reliable sST2 assessment.
sST2 measurement offers prognostic insights across diverse patient populations.